2035818-24-5
2035818-24-5
Chemical Structure
Bexicaserin
Synonym(s): LP352
- CAS No.: 2035818-24-5
- Formula:C15H19F2N3O
- Molecular Weight:295.33
InChIKey: KGOOOHQKLRUVSF-VIFPVBQESA-N
SMILES: FC(F)CNC(C1=C2C3=C(C=C1)CNCCN3C[C@@H]2C)=O
Biological Activity: Bexicaserin (LP352) is a 5-HT2C receptor agonist with potential for studying obesity and psychiatric-related disorders (such as epilepsy)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bexicaserin | 99.84% | Bexicaserin (LP352) is a 5-HT2C receptor agonist with potential for studying obesity and psychiatric-related disorders (such as epilepsy). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Pędzich BD, et al. Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice. Neuropsychopharmacology. 2022 Jun;47(7):1304-1314. [Content Brief]
- [2]. Kaye R, et al. Searching for safer and more effective medications in the management of seizure disorders: a 5-HT2C superagonist[C]//EPILEPSIA. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2023, 64: 315-315.
